Research Paper Volume 13, Issue 13 pp 17914—17929
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis
Figure 8. Roxadustat effect on common AEs. Forest plots of (A) cardiac-specific AE, (B) hypertension (C) liver injury (D) worsening chronic renal failure (in NDD subgroup), (E) urinary tract infections (UTI), (F) diarrhea, (G) hyperkalemia.